Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2523871122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Ching-Chung Ko und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260. Hauptthemen laut MEDLINE: Mycobacteriophages, Genome, Viral, DNA, Viral. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH (NIH), Howard Hughes Medica.
Abstract (Originalsprache)
Bacteriophages show therapeutic promise for treating bacterial pathogens including nontuberculous mycobacteria (NTM). A major impediment is the paucity of therapeutically useful phages and the great variation in the phage infection profiles, especially among Mycobacterium abscessus clinical isolates. These limitations—together with the abundance of mycobacteriophage genes of unknown function—could be addressed by synthetic genetic construction of viruses in which undesirable genes can be eliminated and genetic payloads can be readily added. However, the relatively high G+C% content of mycobacteriophage genomes (64.1%) can be challenging for DNA synthesis using phosphoramidite chemistry, and the genomes are relatively large (40 to 150 kbp) for assembly and rebooting in a bacterial host. Here, we demonstrate efficient de novo synthesis of high G+C% DNA fragments using terminal deoxynucleotidyl transferase chemistry, the reconstruction of complete mycobacteriophage genomes using High-Complexity Golden Gate Assembly, and efficient rebooting via electroporation into Mycobacterium smegmatis . Using this approach, we synthesized the genomes of phages BPs (41.9 kbp, 66.6% G+C%) and Bxb1 (50.5 kbp, 63.6% G+C%), and constructed variants carrying targeted mutations or added payloads. Synthetic construction of mycobacteriophages and their derivatives expands the phage repertoire for therapeutic development and provides versatile tools for advancing mycobacterial genetics and phage-based clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260.
- Research Department, Applied Molecular Biology, New England Biolabs, Ipswich, MA 01938.
- Ansa Biotechnologies, Emeryville, CA 94608.
ORCID-Profile: Graham F Hatfull
Förderung
- NIGMS NIH HHS
- HHS | NIH (NIH)
- Howard Hughes Medica
Zitieren
APA
Ko, C. C., Sikkema, A. P., Lauer, M. J., Amarh, E. D., Garlena, R. A., Russell, D. A., Chew, N., Li, T., Harrison, I. M., Ellefson, J., Hatfull, G. F., & Lohman, G. J. S. (2025). Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2523871122
Vancouver
Ko CC, Sikkema AP, Lauer MJ, Amarh ED, Garlena RA, Russell DA, et al. Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2523871122
BibTeX
@article{Ko2025,
author = {Ko, Ching-Chung and Sikkema, Andrew P and Lauer, Michael J and Amarh, Elizabeth D and Garlena, Rebecca A and Russell, Daniel A and Chew, Nicole and Li, Tan and Harrison, Isa Madrigal and Ellefson, Jared and Hatfull, Graham F and Lohman, Gregory J S},
title = {Genome synthesis, assembly, and rebooting of therapeutically useful high G+C% mycobacteriophages},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2523871122}
}
EUVIMED